Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.67NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CK.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CK.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.16.1 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.16.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.16.1 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.9.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.9.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.9.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.72NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.72NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.72NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.73NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.73NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.73NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDZNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDZNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XEBNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XEBNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XEBNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.263NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.263NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.263NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.180NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.180NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.180NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.464NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.464NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.464NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.234NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.234NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.234NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.231NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.231NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.231NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.243NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.517NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used